Frontiers in Pharmacology (Nov 2017)
Corrigendum: Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice
- Wei Chen,
- Wei Chen,
- Fengchun Shui,
- Fengchun Shui,
- Cheng Liu,
- Xinbo Zhou,
- Xinbo Zhou,
- Wei Li,
- Wei Li,
- Zhibing Zheng,
- Zhibing Zheng,
- Wei Fu,
- Lili Wang,
- Lili Wang
Affiliations
- Wei Chen
- Beijing Institute of Pharmacology and Toxicology, Beijing, China
- Wei Chen
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
- Fengchun Shui
- Beijing Institute of Pharmacology and Toxicology, Beijing, China
- Fengchun Shui
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
- Cheng Liu
- Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, China
- Xinbo Zhou
- Beijing Institute of Pharmacology and Toxicology, Beijing, China
- Xinbo Zhou
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
- Wei Li
- Beijing Institute of Pharmacology and Toxicology, Beijing, China
- Wei Li
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
- Zhibing Zheng
- Beijing Institute of Pharmacology and Toxicology, Beijing, China
- Zhibing Zheng
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
- Wei Fu
- Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, China
- Lili Wang
- Beijing Institute of Pharmacology and Toxicology, Beijing, China
- Lili Wang
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
- DOI
- https://doi.org/10.3389/fphar.2017.00890
- Journal volume & issue
-
Vol. 8
Abstract
No abstracts available.Keywords